Overview

Treatment of Recurrent Bladder Cancer With Dendritic Cells

Status:
Recruiting
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
Treatment of recurrent bladder cancer with dendritic cells
Phase:
Phase 2
Details
Lead Sponsor:
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Collaborator:
Belarusian State Medical University